IP Library Granted Patent US 8,741,832
Granted Patent B2
US 8,741,832 · App. 11/921,064 · Granted Jun 3, 2014

Pegylated albumin and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,741,832
App. No.
11/921,064
Granted
Jun 3, 2014
Kind
B2
Abstract

The present invention provides PEGylated hemoglobins and PEGylated albumins comprising polyethylene glycol (PEG) conjugated to hemoglobin or to albumin, wherein the PEG is a maleimide PEG, an alkylamide PEG, an iodoacetamide PEG, a p-nitro thio-phenyl PEG, a vinyl sulfone PEG, or a mixed disulfide PEG; and PEGylated albumins and PEGylated hemoglobins comprising polyethylene glycol (PEG) attached to a thiolated amino group of albumin or hemoglobin, wherein the amino group is thiolated using dithio sulfo succinimidyl propionate (DTSSP) or dithiosuccinimidyl propionate (DTSP) or dithiobispropionimidate. The invention also provides methods of preparing PEGylated hemoglobins and PEGylated albumins comprising a) reacting hemoglobin or albumin with a thiolating agent and with a PEGylating agent, and b) capping unPEGylated reactive thiols of hemoglobin or albumin with N-ethyl maleimide.

Claims (7)

1. A method of expanding the volume of plasma in a subject in need thereof comprising administering to the subject a plasma volume expander in an amount effective to expand plasma volume, wherein the plasma volume expander comprises a PEGylated albumin having a colloid osmotic pressure of 37-40 mm Hg and a viscosity of 2.0 to 4.0 cP, wherein the PEGylated albumin comprises 6-18 maleimide phenyl polyethylene glycol (PEG) chains, wherein each PEG chain has a molecular weight of 3,000-20,000 daltons, and wherein each maleimide phenyl polyethylene glycol (PEG) chain is conjugated to a thiolated amino group of albumin.

2. The method of claim 1 , wherein the thiolated amino group of albumin is generated using dithio sulfo succinimidyl propionate (DTSSP) or dithiosuccinimidyl propionate (DTSP) or dithiobispropionimidate or iminothiolane or a reagent having a structure X—(CH 2 ) n —S—S—Py, wherein X is a succinimidyl carboxylate or a sulfosuccinimidyl carboxylate or an imidate, n=2-7, and Py represents pyridine moiety.

3. The method of claim 1 , wherein each PEG chain of the PEGylated albumin has a molecular weight of 3,000 to 5,000 daltons.

4. The method of claim 1 , wherein each PEG chain of the PEGylated albumin has a molecular weight of 5,000 daltons.

5. The method of claim 1 , wherein 12 PEG chains are conjugated to albumin.

6. The method of claim 1 , wherein the PEGylated albumin has a viscosity of 2 to 3.7 cP.

7. The method of claim 1 , wherein the plasma volume expander comprises nitroxyl radicals covalently attached to the thiolated PEGylated albumin.

Assignments (4)
MERGER AND CHANGE OF NAME Recorded Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
CHANGE OF NAME Recorded Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036888/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036875/0057 →
CONFIRMATORY LICENSE Recorded Jul 7, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036074/0452 →